Nobel Biocare Implants: Systems, Workflow & Digital Tools

Nobel Biocare sits at the convergence of implant science and digital dentistry — a combination the brand has been building toward since its roots in Prof. Per-Ingvar Brånemark’s 1950s research into osseointegration. For practice owners and clinicians evaluating implant systems today, the relevant question isn’t whether Nobel Biocare has history; it’s whether the current product stack holds up in a modern, digitally connected workflow.

The Implant Systems, Explained

Nobel Biocare’s implant portfolio is broader than many clinicians realize. At the core are three main body designs: NobelActive, NobelParallel, and NobelReplace, now unified under the S Series umbrella. All three share the same NP conical connection and are available with Nobel Biocare’s anodized surfaces — TiUltra and TiUnite — according to the company’s own product documentation.

The S Series design philosophy centers on biological width and minimizing microgap risk. A precision-fit conical connection reduces the potential for bacterial leakage at the implant-abutment interface, which is a genuine clinical concern rather than a marketing talking point. That said, long-term marginal bone stability depends on far more than connection geometry: surgical protocol, bone quality, and prosthetic loading all play roles.

The flagship NobelActive is engineered specifically for compromised bone — gradual bone condensing during insertion and built-in platform shifting make it a reasonable first choice when bone density is a variable. For straightforward cases, NobelParallel S offers predictability without the added cost of the more specialized design.

In November 2024, Nobel Biocare also introduced the NobelZygoma TiUltra, an extension of the zygoma implant line with an updated surface treatment. Zygoma cases remain a small but high-acuity slice of practice volume; if that’s part of your scope, it’s worth requesting the clinical documentation directly from the company.

One more line worth knowing: NobelPearl, the brand’s ceramic (zirconia) implant. Patient demand for metal-free solutions is real, though the long-term evidence base for ceramic implants is still thinner than for titanium. Nobel Biocare has been transparent that the portfolio is titanium-first, with ceramic as an option rather than the default.

The Digital Workflow: DTX Studio

The DTX Studio suite is where Nobel Biocare competes most directly on digital workflow. The platform spans three modules: DTX Studio Clinic handles diagnostics and imaging; DTX Studio Implant covers treatment planning and guided implant surgery; and DTX Studio Lab connects the practice to the lab side. Nobel Biocare describes the suite as “one coherent, open software” — the word “open” matters here, because it signals compatibility with third-party scanners and design tools rather than a closed ecosystem.

In practice, the openness has limits. DTX Studio is optimized for Nobel Biocare’s own restorative components, and clinicians using a mix of implant brands may find the integration less fluid outside Nobel’s ecosystem. That’s a real trade-off worth discussing with your lab before committing to the platform.

The 3Shape TRIOS Partnership

In mid-2025, Nobel Biocare announced a distribution partnership with 3Shape, becoming an official channel for TRIOS intraoral scanners in select markets — with availability beginning by end of June 2025, according to a report in Dentistry Today. This is a notable move. Nobel Biocare is now offering a scan-to-restoration workflow that doesn’t require clinicians to source hardware and software from separate vendors.

For practices already considering a TRIOS scanner, it’s worth getting quotes through both channels. If you want to compare options more broadly, our guide to the best intraoral scanner covers the competitive landscape. The Nobel-3Shape bundle may offer convenience; whether it offers the best per-component value depends on your negotiating position and existing lab relationships.

Regeneratives: The creos Line

The creos brand — membranes, grafting materials, and tissue regeneration products — launched in 2014 and has grown to more than 20 products across three in-house manufacturing sites, per Nobel Biocare’s own reporting. Handling bone and soft tissue augmentation within the same product family as your implant system has workflow advantages, particularly for practices doing a significant volume of staged augmentation cases. Whether creos products outperform comparable offerings from Geistlich, Botiss, or other dedicated regenerative specialists is a separate clinical question; the literature on any specific product should drive that decision.

Corporate Context

Nobel Biocare operates as a brand within Envista Holdings Corporation (NYSE: NVST), alongside Ormco, DEXIS, Kerr, and more than 30 other dental brands. Envista reported Q4 2024 sales of $653 million and Q1 2025 sales of $617 million, with dental implants — including Nobel Biocare, Implant Direct, and Alpha-Bio — cited as a strong performer in recent filings. Stefan Nilsson has served as President of Nobel Biocare since July 2024, bringing experience from the DSO sector prior to his appointment.

The Envista structure matters for practice buyers. Pricing, distribution, and support decisions increasingly run through a corporate layer. For high-volume implant practices, understanding whether your rep is empowered to negotiate or constrained by national contracts is worth a direct conversation.

Where to Start

For most implant practices new to the Nobel Biocare ecosystem, NobelActive S or NobelParallel S covers the majority of clinical scenarios without overcomplicating the prosthetic inventory. Pair that with DTX Studio Implant if digital dentistry workflow is a priority. If your lab is already running 3Shape on their end, the new TRIOS distribution arrangement could simplify the scan-to-design handoff considerably.

The brand’s depth — over 65 years of implant research, a full regenerative line, and an evolving digital suite — is genuine. The question for any practice is whether that depth translates into the specific workflows you actually run, not just the ones that look good in a product brochure.